Septa Pharma’s Post

We are thankful to all the attendees for participating in our webinar on, “Overview of PMDA Clinical Trial Consultation”. In case you couldn’t attend, revisit the session here and access the archived webinar here. https://lnkd.in/gdf5nrft #Japan #MedicinalProducts #Pharmaceuticals #clinicaltrial #Freyr #FreeWebinar #Webinar #RegulatoryAffairs 

We are thankful to all the attendees for participating in our webinar on, “Overview of PMDA Clinical Trial Consultation”. In case you couldn’t attend, revisit the session here and access the archived webinar here. https://lnkd.in/gdf5nrft #Japan #MedicinalProducts #Pharmaceuticals #clinicaltrial #Freyr #FreeWebinar #Webinar #RegulatoryAffairs 

Synchrotron XRPD continues to evolve, offering new opportunities for advanced structural and microstructural characterization of pharmaceuticals. Don't miss the chance to learn about the latest advances in this area at the 4th SPS-XRPD event on the Novartis Campus in Basel. This event will feature three leading international experts who will share their insights and expertise. Join us for learning and networking ! #SynchrotronXRPD #Pharmaceuticals #PharmaceuticalScience #StructuralCharacterization #Microstructuralcharacterization #SPSXRPD #PowderDiffraction #Polymorphism #PairDistributionFunction #CoprocessedAPI

A dedicated session on Polymorphism and 💫Synchrotron X-ray Powder Diffraction for #pharmaceutics

We've been locking in exhibitors and sponsors for Asembia's AXS25 Summit as the summer moves along. We're excited to be planning and welcome you to get in touch with us if participating as an exhibitor or sponsor is on the radar. 2025 is going to be an amazing conference with amazing attendees connecting, collaborating, and crafting the future of the pharmacy industry. #specialtypharmacy #pharmacy #pharma #marketaccess #asembia25 #patientaccess #patientservices #digitalhealth #pharmaceuticals #pharmacists #pharmacyconference #pharmaconference

The public comment period for the  draft of USP Drug Classification 2025 (USP DC 2025) is open until October 31, 2024. The anticipated publication date for USP DC 2025 is January 15, 2025. We invite you to review the proposed draft➡️: https://ow.ly/ySUh50TQb4M #Pharmaceuticals #DrugClassification #USPScience

Cali is a great case study of how to do things right. Join us for an lively discussion.#market strategy #innovation #pharma #reimbursement #healthcare #valueaddedmedicines #womenshealth #lifesciences #505(b)(2)

"Esteemed Pharma Leaders," Inviting you to PharmaLytica 2024, May 30 - June 1 at HITEX, Hyderabad, for a celebration of a decade of pharmaceutical innovation. We'd like to extend a VIP invitation. Let’s connect to explore your participation in this landmark event. more details: sathik.basha@informa.com #PharmaIndustry #PharmaInnovation #Biopharma #Pharmaceuticals #MedicineDevelopment #HealthcareTech #DrugDiscovery #MedicalResearch #ClinicalTrials #PharmaConference #LabEquipment #LabAutomation #PharmaMachinery #LabInstruments #PharmaManufacturing #LabTechnology #PharmaLab #MachineryAutomation #LabTesting #LabSafety

4th SPS-XRPD Workshop (June 10th-11th, Basel, Switzerland) https://lnkd.in/ehVdTt_G #SynchtrotronRadiation #PowderDiffraction #Polymorphism #SynchrotronXRPD #PairDistributionFunction #Pharmaceuticals #PharmaceuticalScience #CoprocessedAPI

The #drugdevelopment journey can be daunting. But do not fear. There’s the 505(b)(2) pathway. So if you value efficiency and speed – while balancing quality and innovation – read our insights into this accelerated path: https://bit.ly/3ZNIGnA #Pharmaceuticals #DrugDevelopmentPathways